Innovating Works

EU2P

Financiado
European programme in Pharmacovigilance and Pharmacoepidemiology
The Eu2P training network in Pharmacovigilance and Pharmacoepidemiology will meet the needs of industry,regulatory authorities and academia at the European level. It will give access to a harmonised training programme that gathers... The Eu2P training network in Pharmacovigilance and Pharmacoepidemiology will meet the needs of industry,regulatory authorities and academia at the European level. It will give access to a harmonised training programme that gathers complementary specialized and eminent European partners. The Eu2P consortium consists of course providers with aproven record including the University of Bordeaux (Eu2P coordinator), the Autonomous University of Barcelona, the Erasmus University Medical Center, the University of Utrecht, the University of Hert[ordshire, the University of Verona, the Karolinska Institute and the European Medicines Agency. It will deliver programmes in harmacovigilance and Pharmacoepidemiology for continuing education diploma, Master’s degree as well as PhD and a short course orientated towards risk communication. Targetedaudiences will be all those involved in the medicine evaluation processes including specialists from academia,industry and regulatory bodies as well as non-specialists (e.g. journalists, ethics committee members, patient organizations...). The Eu2P project is composed of one management work package (WP), one administrative WP and six programme topic WPs. This structure leaves open the addition of WPs by other partners. Moduleswill be developed in each programme topic WP to meet the needs of each type of course and target audience leading to WP cross-interaction. To facilitate access and flexibility (modular workload), the Eu2P programme will be based on English blended learning: a mix of face-to-face, e-Teaching and e-Learning courses. The first phaseof the project (1 year) will establish the Eu2P programme and the e-Teaching and e-Learning centre. The second phase (4 years) will deliver, evaluate and promote the training programmes. Long-term viability of the programme will be assured by the learning experience and the resulting quality of trained persons, the demand for these and the financial balance. ver más
30/06/2016
ROCHE
8M€
Duración del proyecto: 81 meses Fecha Inicio: 2009-09-01
Fecha Fin: 2016-06-30

Línea de financiación: concedida

El organismo FP6 notifico la concesión del proyecto el día 2016-06-30
Presupuesto El presupuesto total del proyecto asciende a 8M€
Líder del proyecto
F. HOFFMANNLA ROCHE AG No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico TRL 4-5